Skip to main content
. 2021 Jun 22;16(18):2786–2801. doi: 10.1002/cmdc.202100283

Scheme 2.

Scheme 2

Reagents and conditions: (ia) method D a): TBDMSCl, imidazole, CH2Cl2, rt, 16 h; (ib) method D b): TBDMSCl, NaH, CH2Cl2, 0 °C→ rt, 16 h; (ii) method E: nBuLi, B(OiPr)3, THF, −78 °C→rt, 3 h; (iii) method F: TBAF, K2HPO4, THF, rt, 16 h.